Category: Replacement Heart ValvesSyndicate content

Heart Valves

Appeals court stays ban on Medtronic's CoreValve device

April 21, 2014 by Brad Perriello

A federal appeals court stays a ban on U.S. sales of Medtronic's CoreValve replacement heart valve "pending further notice" in a patent infringement battle with Edwards Lifesciences and its Sapien transcatheter aortic valve implant.

Appeals court stays ban on Medtronic's CoreValve device

Edwards Lifesciences decries Medtronic's 'scare tactics' in CoreValve dispute

April 21, 2014 by Brad Perriello

Edwards Lifesciences urges a federal appeals court to ignore Medtronic's alleged 'scare tactics' over a pending ban on its CoreValve replacement heart valve.

Edwards Lifesciences decries Medtronic's 'scare tactics' in CoreValve dispute

UPDATED April 21, 2014, at 12:30 p.m. with comment from Medtronic.

UPDATED April 21, 2014, at 3:45 p.m. with comment from Edwards Lifesciences.

Cardiac Dimensions closes $20M equity round

April 17, 2014 by Brad Perriello

Cardiac Dimensions raises $20 million from a syndicate of international investors for its Carillon mitral valve implant.

Cardiac Dimensions closes $20M equity round

Cardiac Dimensions said it raised $20 million from a syndicate of international investors for its Carillon mitral valve implant.

M.H. Carnegie & Co. and Lumira Capital led the round for Kirkland, Wash.-based Cardiac Dimensions, according to a press release. Investors in Australia, the U.S. and Canada also participated, the company said.

TAVI: Judge chides Medtronic, Edwards offers consolation prize in infringement case

April 17, 2014 by Arezu Sarvestani

A U.S. District Judge defends a ban on Medtronic's newly approved CoreValve transcatheter aortic valve implantation system, saying the company willfully ignored the law in bringing the device to the U.S. after it was found to infringe on a patent held by Edwards Lifesciences.

Judge: Medtronic thumbed nose at the law in bringing CoreValve to U.S.

U.S. District Judge Gregory Sleet chided Medtronic (NYSE:MDT) this week after issuing a preliminary ban on the medtech titan's CoreValve transcatheter aortic valve implantation system.

TAVI: Medtronic vows to appeal CoreValve ban in patent loss to Edwards Lifesciences

April 14, 2014 by Arezu Sarvestani

Medtech titan Medtronic plans to seek immediate appeal of a preliminary court injunction banning sales of its CoreValve transcatheter aortic valve implantation system.

TAVI: Medtronic has 7 days to appeal CoreValve ban in patent loss to Edwards Lifesciences

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

TAVI: Court limits U.S. sales of Medtronic's CoreValve

April 11, 2014 by Arezu Sarvestani

Edwards Lifesciences lands a preliminary injunction limiting Medtronic from selling its CoreValve transcatheter aortic valve implantation system in the U.S.

TAVI: Court bans U.S. sales of Medtronic's CoreValve

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Tendyne Holdings secures $25M for transcatheter mitral valves

April 10, 2014 by Arezu Sarvestani

Minnesota-based Tendyne Holdings raises $25 million in a Series C funding round supporting its transcatheter mitral valve implantation systems for treating mitral regurgitation.

Tendyne Holdings secures $25M for transcatheter mitral valves

Medtech startup Tendyne Holdings landed $25 million in Series C funding, planning on using the new cash for further research & development of its transcatheter mitral valve technology.

The 4-year-old company's device provides minimally invasive treatment of mitral regurgitation. Tendyne is working on engineering an implantation system that would allow physicians to re-position or retrieve the valve even after full deployment.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp